Article summary
Amsterdam, Netherlands, August 11, 2025 β PsyPal has reached a major milestone with the inclusion of its first patient in the multi-site clinical trial investigating psilocybin therapy for psychological and existential distress in people with progressive, life-limiting illnesses. The first patient has been included at University Medical Center Groningen (UMCG), Netherlands, one of four specialised [β¦] The post First Patient Included Marks Major Milestone in EU-Funded Clinical Trial appeared first on OPEN Foundation.
Continue to the original publication for the complete article.